CWH Capital Management’s AbbVie ABBV Stock Holding History

CWH Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$5M	Sell	46,654 -44,352	-49%	-$4.26M	2.1%	16
2020 Q3	$7.97M	Sell	91,006 -2,448	-3%	-$230K	3.63%	9
2020 Q2	$9.18M	Sell	93,454 -3,320	-3%	-$292K	4.47%	6
2020 Q1	$7.37M	Sell	96,774 -4,869	-5%	-$415K	3.87%	8
2019 Q4	$9M	Sell	101,643 -1,220	-1%	-$101K	3.6%	8
2019 Q3	$7.79M	Buy	102,863 +16,731	+19%	+$1.15M	3.09%	9
2019 Q2	$6.26M	Buy	86,132 +80,164	+1,343%	+$6.3M	2.54%	12
2019 Q1	$481K	Hold	5,968	–	–	0.2%	42
2018 Q4	$550K	Buy	5,968 +334	+6%	+$29.4K	0.27%	39
2018 Q3	$533K	Hold	5,634	–	–	0.25%	39
2018 Q2	$522K	Buy	5,634 +967	+21%	+$94.4K	0.24%	37
2018 Q1	$442K	Hold	4,667	–	–	0.21%	37
2017 Q4	$451K	Hold	4,667	–	–	0.21%	38
2017 Q3	$415K	Hold	4,667	–	–	0.2%	39
2017 Q2	$338K	Hold	4,667	–	–	0.18%	40
2017 Q1	$304K	Hold	4,667	–	–	0.16%	41
2016 Q4	$292K	Hold	4,667	–	–	0.18%	40
2016 Q3	$294K	Buy	+4,667	New	+$302K	0.2%	40

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CWH Capital Management's ABBV Position: Q4 2020 in Review

CWH Capital Management reduced its AbbVie (ABBV) stake by 49% in Q4 2020, selling an estimated $4.26M and leaving 46,654 shares worth $5M. The position accounts for 2.1% of the portfolio, ranked #16.

CWH Capital Management first reported a position in ABBV in Q3 2016 and has held it in 18 quarters since. The position peaked at $9.18M in Q2 2020. 2,599 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

CWH Capital Management held 46,654 shares of AbbVie worth $5M as of Q4 2020.
CWH Capital Management sold 44,352 AbbVie shares in Q4 2020, an estimated $4.26M.
AbbVie made up 2.1% of CWH Capital Management's portfolio in Q4 2020, its #16 holding.
CWH Capital Management first reported a position in AbbVie in Q3 2016 and has held it in 18 quarters since.
CWH Capital Management's AbbVie position peaked at $9.18M in Q2 2020.
2,599 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on CWH Capital Management's 13F filing for Q4 2020, filed 2 Feb 2021.